Sarepta Therapeutics (SRPT) Non-cash Items (2010 - 2025)

Sarepta Therapeutics' Non-cash Items history runs 16 years deep, the most recent figure standing at $5.8 million for Q4 2025.

• In Q4 2025, Non-cash Items fell 98.64% year-over-year to $5.8 million; the TTM figure through Dec 2025 stood at $5.8 million (down 98.64% YoY), while the FY2025 annual figure was $5.8 million, down 98.64% from the prior year.
• Non-cash Items was $5.8 million for Q4 2025 at Sarepta Therapeutics, down from $425.0 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $425.0 million in Q4 2024 to a low of $4.7 million in Q4 2022.
• Historically, Non-cash Items has averaged $138.0 million across 5 years, with a median of $6.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Non-cash Items surged 7041.17% in 2024, then plunged 98.64% in 2025.
• A 5-year view of Non-cash Items shows it stood at $248.5 million in 2021, then sank by 98.11% to $4.7 million in 2022, then increased by 26.84% to $6.0 million in 2023, then soared by 7041.17% to $425.0 million in 2024, then slumped by 98.64% to $5.8 million in 2025.
• The last three Non-cash Items figures came in at $5.8 million (Q4 2025), $425.0 million (Q4 2024), and $6.0 million (Q4 2023), per Business Quant data.